Part 6 — Psychological Drivers of Addiction: Stress, Emotion, and Trauma

Mohamad-Ali Salloum, PharmD • April 6, 2026

Share

  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button


How emotional dysregulation, traumatic experiences, and chronic stress shape vulnerability to addiction

Addiction is often described as a brain‑based disorder, but psychological factors—especially stress, trauma, and emotional regulation difficulties—play equally powerful roles in shaping who becomes addicted, how addiction progresses, and why relapse occurs. Recent findings highlight the profound interplay between early relational experiences, chronic emotional distress, and altered stress‑response systems. These factors do not simply influence addiction from the outside; they fundamentally reshape the brain’s motivational and emotional circuitry.

This section explores how psychological forces interact with biological systems to increase vulnerability to addictive behaviors.

1. Early Attachment and Trauma: Emotional Foundations of Vulnerability 🧩

Early relational trauma—such as inconsistent caregiving, emotional neglect, or chronic instability—can dysregulate the stress‑response system and impair the ability to regulate emotions later in life. These disruptions affect brain regions involved in self‑awareness, emotional processing, and reward, including the insula, which plays a major role in interpreting internal emotional states.

In simple terms:
Early emotional wounds weaken the brain’s ability to manage stress, making addictive coping more likely.

2. Stress: A Core Driver of Addiction and Relapse ⚡

Stress is one of the most powerful psychological triggers for both substance use and relapse. Chronic or repeated stress disrupts the body’s adaptive stress mechanisms, making emotional and physiological recovery more difficult. When individuals face ongoing stress—such as trauma history, conflict, or unstable environments—the stress system becomes hypersensitive.

  • increases craving
  • reduces impulse control
  • amplifies negative emotional states
  • makes substance use feel like quick relief
  • strengthens associations between stress and drug-seeking behavior
In simple terms:
When stress builds up faster than the brain can cope, addictive behaviors become an escape valve.

3. Emotional Dysregulation: When Feelings Become Overwhelming 🌧️

Emotional dysregulation—difficulty understanding, tolerating, or managing emotions—is consistently linked to addiction. Treatments designed to improve emotional regulation have shown positive outcomes, reducing relapse by helping individuals build healthier tools for handling distress.

Different substances also affect emotional processing differently:

  • Alcohol dependence: blunted response to negative emotional cues
  • Cocaine dependence: heightened sensitivity to negative emotions
  • Opioid dependence: strong links to amygdala dysfunction
In simple terms:
People don’t always use substances to feel good—they often use them to stop feeling bad.

4. Trauma and PTSD: A Powerful Predictor of Substance Misuse 🔥

Trauma and substance use disorders frequently occur together. Individuals with PTSD face heightened emotional vulnerability and often struggle to regulate both negative and positive emotions. Substances may temporarily numb distress, but this relief reinforces dependence over time.

  • trauma increases emotional vulnerability
  • substances provide short-term escape
  • emotional dysregulation intensifies
  • avoidance becomes a learned strategy, deepening dependence
In simple terms:
Trauma disrupts emotional stability, and substances become a shortcut to escape overwhelming internal experiences.

5. How Psychological Factors Contribute to Relapse 🔄

Relapse is frequently triggered by psychological vulnerabilities—many rooted in earlier trauma, chronic stress, or emotional dysregulation.

Common psychological relapse triggers:

  • negative mood or distress
  • family conflict or high emotional tension
  • cravings triggered by emotional cues
  • peer pressure
  • unresolved trauma symptoms
In simple terms:
Relapse happens when emotional discomfort collides with old learned coping habits.

6. An Integrated Picture: Emotions, Stress, and Trauma in Addiction 🧠

Across research, a unified picture emerges:

  • early attachment disruptions create long-term vulnerability
  • trauma destabilizes emotional and stress systems
  • emotional dysregulation fuels cycles of negative reinforcement
  • chronic stress reduces resilience and heightens cravings
  • psychological suffering becomes interconnected with drug-seeking behavior

This explains why psychological treatment—including emotional regulation training, trauma processing, and stress resilience building—is essential in addiction recovery.

✅ Quick Quiz: Test Your Understanding

Try answering these before scrolling back!

  1. How do early attachment disruptions increase addiction risk?
  2. Why is stress considered one of the strongest triggers for relapse?
  3. Describe one way emotional dysregulation contributes to addictive behavior.
  4. How does PTSD increase vulnerability to substance use disorders?
  5. Give one example of a psychological relapse trigger and explain its power.

References:

  1. Unterrainer HF. Addiction, attachment, and the brain: a focused review of empirical findings. Front Hum Neurosci. 2025;19. 1 
  2. Sinha R. Stress and substance use disorders: risk, relapse, and treatment outcomes. J Clin Invest. 2024;134(16). 2 
  3. Chrétien S, Giroux I, Smith I, et al. Emotional Regulation in Substance-Related and Addictive Disorders Treatment: A Systematic Review. J Gambl Stud. 2025;41:353–448. 3 
  4. Hand LJ, Paterson LM, Lingford-Hughes AR. Emotional dysregulation as a driver of relapse. Transl Psychiatry. 2024;14:467. 4 
  5. Bowen AM, Calder R, Neale J, et al. Emotion Regulation in the Association Between PTSD and Substance Use: A Systematic Review. Trauma Violence Abuse. 2024;27(1):3–21. 5 
  6. Abdelkader Husiny TM. A Scoping Review of Factors Contributing to Relapse in Substance Use Disorders. Modern Journal of Health and Applied Sciences. 2025;2(1). 6 


List of Services

    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button

    ABOUT THE AUTHOR

    Mohamad-Ali Salloum, PharmD

    Mohamad Ali Salloum LinkedIn Profile

    Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.

    Share

    Recent articles:

    By Mohamad-Ali Salloum, PharmD May 7, 2026
    References: McMurray JJV, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med . 2014;371(11):993–1004. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med . 2007;357:2109–2122. Kastelein JJP, Akdim F, Stroes ESG, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med . 2008;358:1431–1443. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med . 2008;358:2545–2559. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med . 1991;324:781–788. Packer M, Anker SD, Butler J, et al. Effect of empagliflozin on cardiovascular and renal outcomes. N Engl J Med . 2020;383:1413–1424. Ioannidis JPA. Surrogate endpoints in clinical trials: are we being misled? BMJ . 2013;346:f314.
    By Mohamad-Ali Salloum, PharmD May 4, 2026
    References: Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci . 2015;16(7):403‑18. Frisaldi E, Shaibani A, Benedetti F, Pagnini F. Placebo and nocebo effects associated with pharmacological interventions: an umbrella review. BMJ Open . 2023;13:e077243. Colloca L, Finniss D. Nocebo effects, patient‑clinician communication, and therapeutic outcomes. JAMA . 2012;307(6):567‑8. Howard JP, Wood FA, Finegold JA, et al. Side effect patterns in a blinded, randomized trial of statin, placebo, and no treatment. N Engl J Med . 2021;385(23):2180‑9. Penson PE, Mancini GBJ, Toth PP, et al. Introducing the “drucebo” effect in statin therapy. J Cachexia Sarcopenia Muscle . 2018;9(6):1023‑33. Barnes K, Faasse K, Geers AL, et al. Can positive framing reduce nocebo side effects? Front Pharmacol . 2019;10:167. Caliskan EB, Bingel U, Kunkel A. Translating knowledge on placebo and nocebo effects into clinical practice. Pain Rep . 2024;9(2):e1142. von Wernsdorff M, Loef M, Tuschen‑Caffier B, Schmidt S. Effects of open‑label placebos in clinical trials: a systematic review and meta‑analysis. Sci Rep . 2021;11:3855.
    By Mohamad-Ali Salloum, PharmD May 4, 2026
    References: Zaniletti I, Larson DR, Lewallen DG, Berry DJ, Maradit Kremers H. How to distinguish correlation from causation in orthopaedic research. J Arthroplasty. 2023;38(4):634–637. Rush J, Ajami M, Look KA, Margolis A. Statistics review part 10: causality and confounding. J Pharm Soc Wis. 2014;17(1):45–52. Koopmans E, Schiller C. Understanding causation in healthcare: an introduction to critical realism. Qual Health Res. 2022;32(8–9):1207–1214. Kahlert J, Gribsholt SB, Gammelager H, Dekkers OM, Luta G. Control of confounding in the analysis phase – an overview for clinicians. Clin Epidemiol. 2017;9:195–204. Shi AX, Zivich PN, Chu H. A comprehensive review and tutorial on confounding adjustment methods for estimating treatment effects using observational data. Appl Sci (Basel). 2024;14(9):3662. Gao Y, Xiang L, Yi H, Song J, Sun D, Xu B, et al. Confounder adjustment in observational studies investigating multiple risk factors: a methodological study. BMC Med. 2025;23:132. Ho FK, Brown J, Galwey NW. Regression adjustment for causal inference. BMJ Med. 2025;4:e000816. Correia LCL, Mascarenhas RF, Menezes FSC, Oliveira Junior JS, Vaccarino V, Ross JS, et al. Confounder selection in observational studies in high‑impact medical and epidemiological journals. JAMA Netw Open. 2025;8(7):e2524176.
    By Mohamad-Ali Salloum, PharmD May 1, 2026
    Explore the difference between Sensitivity and Specificity
    By Mohamad-Ali Salloum, PharmD April 29, 2026
    References: Zaniletti I, Larson DR, Lewallen DG, Berry DJ, Maradit Kremers H. How to Distinguish Correlation from Causation in Orthopaedic Research. J Arthroplasty. 2022;38(4):634‑637. [pmc.ncbi.nlm.nih.gov] Association of Health Care Journalists. Correlation vs. Causation. [healthjournalism.org] Rush J, Ajami M, Look K, Margolis A. Statistics Review Part 10: Causality and Confounding. J Pharm Soc Wis. [jpswi.org] Biostat Prime. Correlation vs Causation: Meaning, Differences & Examples. [biostatprime.com] Koopmans E, Schiller C. Understanding Causation in Healthcare: An Introduction to Critical Realism. Qual Health Res. 2022;32(8–9):1207–1214. [pmc.ncbi.nlm.nih.gov] 
    By Mohamad-Ali Salloum, PharmD April 27, 2026
    References: Very Big Brain. Somatic Memories: How Physical Sensations Trigger Past Memories and Emotions . 2023 Nov 26. [verybigbrain.com] Misattribution of arousal. Wikipedia . 2026. [en.wikipedia.org] Zimbardo P. The Misattribution of Arousal Study (Dutton & Aron) . 2026. [zimbardo.com] Higgins L. Why You Feel Anxious After Drinking Coffee . TIME. 2025 Nov 11. [time.com] Double KS. Metacognitive ability is associated with reduced emotion suppression . Scientific Reports. 2026 Jan 28. [nature.com] Merkebu J et al. What is metacognitive reflection? Front Educ. 2023 Apr 5. [researchgate.net] Meyers S et al. Cognitive Reappraisal is More Effective for Regulating Emotions than Moods . Affective Science. 2025 Jun 6. [link.springer.com] 
    By Mohamad-Ali Salloum, PharmD April 25, 2026
    Are they the same?
    By Mohamad-Ali Salloum, PharmD April 23, 2026
    A Practical Guide for the Public.
    By Mohamad-Ali Salloum, PharmD April 21, 2026
    Did you know that your emotions are just suggestions?
    By Mohamad-Ali Salloum, PharmD April 19, 2026
    Short-form videos like Reels and TikTok rapidly trigger dopamine, stress, and attention circuits—discover how they impact your brain, mood, and focus, plus practical tips to restore balance.
    More Posts